|
| .
.
.
.
 | .Click on blue triangle to read clinical research studies. Information is displayed as:
Treatment Agent(s)/ Physician/ Study Number. .
 Eye
90Y-ibritumomab tiuxetan, Rituxan, Rituximab, Zevalin / Bita Esmaeli / 2003-0696
Cyclophosphamide, Filgrastim, GM-CSF, Ifosfamide, Topotecan / Robert J. Wells / 2004-0079
Proton Therapy, Radiation / Dan Gombos / 2005-0883
None / Elie Mouhayar / 2006-0921
None / Bita Esmaeli / 2007-0584
Panitumumab / Dennis P. Hughes / 2007-0615
0.25%), Cyclosporine ophthalmic emulsion 0.05%, FML Forte® (fluorometholone ophthalmic suspension, Refresh Endura™ lubricant eye drops / Bita Esmaeli / 2007-0757
None / Bita Esmaeli / 2008-0266
Carboplatin, Etoposide, Filgrastim, Vincristine / Peter E. Zage / COGARET0231
Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Filgrastim, Mesna, Radiation, Radiation & Chemo, Thiotepa, Vincristine Sulfate / Peter E. Zage / COGARET0321
Carboplatin, Etoposide, Vincristine / Peter E. Zage / COGARET0332
Biopsy, Lymphatic Mapping / Bita Esmaeli / GSP00-106
None / Cynthia G. Segal / ID01-024
Alpha-Tocopherol, Selenomethionine / Elise D. Cook / S00-00B
Fallopian Tube
Gallbladder
Gastric
Gastrointestinal
Gastrointestine
Genitourinary
GIST
Gynecology
Head And Neck
Hematologic Disorder
Infection
Kidney
Laboratory
Leukemia
Liver | .
.
.
.
 |